4D Molecular Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FDMT and other ETFs, options, and stocks.

About FDMT

4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution. 

CEO
David H. Kirn
CEODavid H. Kirn
Employees
196
Employees196
Headquarters
Emeryville, California
HeadquartersEmeryville, California
Founded
2013
Founded2013
Employees
196
Employees196

FDMT Key Statistics

Market cap
516.13M
Market cap516.13M
Price-Earnings ratio
-4.02
Price-Earnings ratio-4.02
Dividend yield
Dividend yield
Average volume
961.06K
Average volume961.06K
High today
High today
Low today
Low today
Open price
$10.75
Open price$10.75
Volume
0.00
Volume0.00
52 Week high
$12.34
52 Week high$12.34
52 Week low
$2.24
52 Week low$2.24

Stock Snapshot

4D Molecular Therapeutics(FDMT) stock is priced at $10.00, giving the company a market capitalization of 516.13M. It carries a P/E multiple of -4.02.

4D Molecular Therapeutics(FDMT) stock opened on 2026-04-09 at $10.75. The price climbed to — and dipped to —.

The 4D Molecular Therapeutics(FDMT)'s current trading volume is 0, compared to an average daily volume of 961.06K.

During the past year, 4D Molecular Therapeutics(FDMT) stock moved between $2.24 at its lowest and $12.34 at its peak.

During the past year, 4D Molecular Therapeutics(FDMT) stock moved between $2.24 at its lowest and $12.34 at its peak.

Analyst ratings

80%

of 10 ratings
Buy
80%
Hold
20%
Sell
0%

People also own

Based on the portfolios of people who own FDMT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.